Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Celyad Sa ADR
(NQ:
CYAD
)
0.4700
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 18, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Celyad Sa ADR
< Previous
1
2
3
4
5
Next >
Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
September 07, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
September 05, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights
September 04, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders
August 24, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad Oncology announces receipt of Nasdaq delisting notice
May 15, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 05, 2023
Via
Benzinga
Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From Nasdaq
May 05, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad Oncology reports first quarter 2023 financial results and recent business highlights
May 05, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad Oncology announces receipt of Nasdaq initial notification on ADS bid price
April 24, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 19, 2023
Via
Benzinga
Celyad Oncology announces receipt of Nasdaq notice
April 04, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad Oncology appoints Georges Rawadi as its new CEO
March 24, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad Oncology reports full year 2022 financial results and recent business highlights
March 23, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Earnings Scheduled For March 23, 2023
March 23, 2023
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter.
Via
Benzinga
Celyad Oncology to announce full year 2022 financial results and host conference call
March 17, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 16, 2023
Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 15, 2023
Via
Benzinga
Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 15, 2023
Gainers ThermoGenesis Holdings, Inc. (NASDAQ: THMO) shares jumped 80% to $3.7820 after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 15, 2023
Via
Benzinga
Why Jounce Therapeutics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
March 15, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 15, 2023
We're beginning the day with a look at the biggest pre-market stock movers traders need to know about for Wednesday morning!
Via
InvestorPlace
Celyad Oncology announces non-cash impairment
March 15, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
REPEAT -- Celyad Oncology SA - Letter to Shareholders
March 01, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad Oncology SA - Letter to Shareholders
February 28, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 20, 2023
Via
Benzinga
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 17, 2023
Gainers Ibio Inc (NYSE: IBIO) shares rose 97% to $1.4787 after the company announced MUC16 as its latest immune-oncology target program.
Via
Benzinga
Celyad Oncology announces the publication of data from its Phase 1 THINK study of CYAD-01
February 09, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 07, 2023
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
